These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4730272)

  • 1. Solid-phase synthesis of lysine vasopressin analogs: (1-beta-mercaptopropionic acid, 8-lysine)-vasopression and (1-beta-mercaptopropionic acid, 8-(epsilon-N-p-toluenesulfonyl)-lysine)-vasopressin.
    Havran RT
    Experientia; 1973 May; 29(5):520-1. PubMed ID: 4730272
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of the substitution of photoreactive groups in positions 4 and 8 of vasopressin.
    Buku A; Yamin N; Gazis D
    Int J Pept Protein Res; 1989 Jul; 34(1):28-32. PubMed ID: 2507457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and some pharmacological properties of (1-alpha-mercaptoacetic acid)-8-lysine-vasopressin and (1-gamma-mercaptobutyric acid)-8-lysine-vasopressin.
    Dyckes DF; Smith CW; Ferger MF; du Vigneaud V
    J Am Chem Soc; 1974 Nov; 96(24):7549-51. PubMed ID: 4427064
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and binding characteristics of two sulfhydryl-reactive probes for vasopressin receptors.
    Pávó I; Kojro E; Fahrenholz F
    FEBS Lett; 1993 Jan; 316(1):59-62. PubMed ID: 8422939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance comparison of neurohypophyseal hormones and analogs: deletion of amino groups and the conformation of lysine vasopressin.
    Glickson JD; Urry DW; Havran RT; Walter R
    Proc Natl Acad Sci U S A; 1972 Aug; 69(8):2136-40. PubMed ID: 4506084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A solid-phase synthesis of [lysine]-vasopressin through a crystalline protected nonapeptide intermediate.
    Meienhofer J; Sano Y
    J Am Chem Soc; 1968 May; 90(11):2996-7. PubMed ID: 5648114
    [No Abstract]   [Full Text] [Related]  

  • 7. Nuclear magnetic resonance spectrum of deamino-lysine-vasopression in aqueous solution and its structural implications.
    Von Dreele PH; Scheraga HA; Dyckes DF; Ferger MF; Du Vigneaud V
    Proc Natl Acad Sci U S A; 1972 Nov; 69(11):3322-6. PubMed ID: 4508326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,6-Aminosuberic acid analogs of lysine- and arginine-vasopressin and -vasotocin. Synthesis and biological properties.
    Hase S; Sakakibara S; Wahrenburg M; Kirchberger M; Schwartz IL; Walter R
    J Am Chem Soc; 1972 May; 94(10):3590-600. PubMed ID: 5032960
    [No Abstract]   [Full Text] [Related]  

  • 9. Solid-phase synthesis with attachment of peptide to resin through an amino acid side chain: (8-lysine)-vasopressin.
    Meienhofer J; Trzeciak A
    Proc Natl Acad Sci U S A; 1971 May; 68(5):1006-9. PubMed ID: 5280519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probes for vasopressin receptors. Attachment of affinity and fluorescent groups in vasopressin.
    Buku A; Gazis D
    Int J Pept Protein Res; 1990 Feb; 35(2):128-32. PubMed ID: 2157680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and properties of 1-deamino-8-L-homolysine-vasopressin.
    Lindeberg G; Kyncl J; Dreyfuss P; Bodanszky M
    J Med Chem; 1972 Jun; 15(6):629-31. PubMed ID: 5030930
    [No Abstract]   [Full Text] [Related]  

  • 12. Arginine-vasopressin, lysine-vasopressin, and oxytocin, C14-labeled in the glycine residue.
    Walter R; Havran RT
    Experientia; 1971 Jun; 27(6):645-6. PubMed ID: 5556440
    [No Abstract]   [Full Text] [Related]  

  • 13. The structure of acetone-lysine-vasopressin as established through its synthesis from the acetone derivative of S-benzyl-L-cysteinyl-L-tyrosine.
    Havran RT; Du Vigneaud V
    J Am Chem Soc; 1969 May; 91(10):2696-8. PubMed ID: 5784946
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthesis and pharmacological properties of des-9-glycine analogs of [Orn8]vasopressin].
    papsuevich OS; Barth T; Chipens GI; Bakharev VD; Gaĭlite EA
    Bioorg Khim; 1988 Jan; 14(1):10-9. PubMed ID: 3382427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia.
    Walter R; Hoffman PL; Flexner JB; Flexner LB
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4180-4. PubMed ID: 1060098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple, high yield synthesis of arginine vasopressin.
    Jones DA; Mikulec A; Mazur RH
    J Org Chem; 1973 Aug; 38(16):2865-9. PubMed ID: 4733443
    [No Abstract]   [Full Text] [Related]  

  • 17. Solid-phase synthesis and pressor potency of (1-deamino-9-ethylenediamine)-lysine-vasopressin.
    Glass JD; Du Vigneaud V
    J Med Chem; 1973 Feb; 16(2):160-1. PubMed ID: 4683112
    [No Abstract]   [Full Text] [Related]  

  • 18. Nuclear magnetic resonance studies of lysine-vasopressin: structural constraints.
    Von Dreele PH; Brewster AI; Bovey FA; Scheraga HA; Ferger MF; Du Vigneaud V
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3088-91. PubMed ID: 5289251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ON THE CONFIGURATION OF A LYSINE -VASOPRESSIN DIMER.
    SCHALLY AV; BARRETT JF
    J Am Chem Soc; 1965 Jun; 87():2497-9. PubMed ID: 14327158
    [No Abstract]   [Full Text] [Related]  

  • 20. The synthesis and pharmacological properties of 4-decarboxamido-8-lysine-vasopressin, 5-decarboxamido-8-lysine-vasopressin, and their 1-deamino analogues.
    Gillessen D; Du Vigneaud V
    J Biol Chem; 1967 Oct; 242(20):4806-12. PubMed ID: 6061422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.